References
- Yoo T J, Roholt O A, Pressman D. Specific binding activity of isolated light chains of antibodies. Science 1967; 157: 707–709
- Matsuoka Y, Moore G E, Yagi Y, Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 1967; 125: 1246–1250
- Solling K. Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay. Scand J Clin Lab Invest 1975; 35: 407–412
- Cole P W, Durie B G, Salmon S E. Immunoquantitation of free light chain immunoglobulins: applications in multiple myeloma. J Immunol Methods 1978; 19: 341–349
- Solling J, Solling K. Free light chains of immunoglobulins in amyloidosis. Acta Med Scand 1979; 206: 283–287
- Gordon J, Howlett A R, Smith J L. Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma. Immunology 1978; 34: 397–404
- Abraham R S, Katzmann J A, Clark R J, Bradwell A R, Kyle R A, Gertz M A. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003; 119: 274–278
- Akar H, Seldin D C, Magnani B, et al. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid 2005; 12: 210–215
- Sanchorawala V, Seldin D C, Magnani B, Skinner M, Wright D G. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant 2005; 36: 597–600